Insider Trading April 3, 2026

Kratos CFO Sells 5,000 Shares Under Prearranged Plan; Company Logs Multiple Defense Contracts and Appointments

Deanna H. Lund executed pre-scheduled sales totaling $348,129 as Kratos announces multiple program wins and a board appointment

By Caleb Monroe KTOS
Kratos CFO Sells 5,000 Shares Under Prearranged Plan; Company Logs Multiple Defense Contracts and Appointments
KTOS

Deanna H. Lund, Executive Vice President and Chief Financial Officer of Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), sold 5,000 shares of the company's common stock on April 1, 2026, under a previously adopted 10b5-1 trading plan. The transactions, carried out at prices ranging from $68.0578 to $72.45, amounted to $348,129. Kratos meanwhile disclosed several contract awards, program partnerships and a board appointment in recent developments.

Key Points

  • Kratos CFO Deanna H. Lund sold 5,000 shares on April 1, 2026, under a 10b5-1 trading plan, generating $348,129 in proceeds.
  • Kratos disclosed multiple program wins and partnerships, including a potential $49.2 million contract for Oriole solid rocket motors and TVC kits, selection by SKY Perfect JSAT for a 5G NTN ground system, and a collaboration with Airbus for an uncrewed combat aircraft program.
  • David King was appointed to Kratos' board of directors and will serve on the Audit Committee; Rocket Lab secured a $190 million contract for 20 hypersonic test flights under a Kratos-led task area.

Insider sale details

Deanna H. Lund, who serves as Executive Vice President and Chief Financial Officer at Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), reported the sale of 5,000 shares of common stock on April 1, 2026, according to a Form 4 filing with the U.S. Securities and Exchange Commission. The trades were executed under a 10b5-1 trading arrangement that Lund adopted on May 20, 2025.

The total proceeds from the sales were $348,129, with execution prices spanning $68.0578 to $72.45. The sales were broken out as follows:

  • 1,800 shares sold at a weighted average price of $68.0578, with individual trade prices ranging from $67.67 to $68.65;
  • 800 shares sold at a weighted average price of $69.6024, with prices ranging from $68.98 to $69.94;
  • 1,600 shares sold at a weighted average price of $70.3123, with prices ranging from $70.02 to $70.86;
  • 600 shares sold at a weighted average price of $71.59, with prices ranging from $71.19 to $72.08;
  • 200 shares sold at a weighted average price of $72.45, with prices ranging from $72.21 to $72.69.

Following these dispositions, Lund directly owns 300,069 shares of Kratos common stock. That total includes 16,626 shares acquired through the company’s Employee Stock Purchase Plan and approximately 20,143 shares held within the company’s 401(k) Plan.


Corporate developments and contract awards

In other disclosures and announcements, Kratos has reported a series of program and corporate developments across defense and aerospace activity.

  • Kratos received a contract from the Naval Surface Warfare Center, Port Hueneme Division, covering production and delivery of up to 36 Oriole solid rocket motors and three Thrust Vector Control (TVC) nozzle kits. If the contract is fully exercised, it could be worth up to $49.2 million. Within that potential total, the rocket motor portion is valued at $39.1 million and the TVC production kits option at $10.1 million.
  • SKY Perfect JSAT Corporation selected Kratos to develop a 5G Non-Terrestrial Network (NTN) ground system as part of its Universal NTN initiative in the Asia-Pacific region.
  • Kratos and Airbus are collaborating on an integrated Uncrewed Collaborative Combat Aircraft system for the German Air Force, with a maiden flight planned for later this year.
  • David King has been appointed to Kratos’ board of directors and will serve on the Audit Committee; King is described as having over four decades of experience in the aerospace and defense sectors.
  • Separately, Rocket Lab, under a task area led by Kratos, secured a $190 million contract for 20 hypersonic test flights for the U.S. Department of Defense.

Collectively, these items underscore Kratos’ active participation in multiple defense and aerospace programs spanning propulsion, non-terrestrial communications infrastructure and collaborative uncrewed aircraft development.


Context and limitations

The insider sale was executed via a pre-established 10b5-1 plan, which is noted in the Form 4 filing. The announced contract values include option elements and are conditional on full exercise where specified. The timing and execution details for program milestones such as the planned maiden flight are described in the company’s announcements but are not further detailed in the regulatory filing concerning the insider sale.


Bottom line

On April 1, 2026, Kratos’ CFO completed a prearranged sale of 5,000 shares totaling $348,129. The company concurrently reported a set of contract awards, partnerships and a board appointment that span its defense and aerospace activities.

Risks

  • Contract values reported include optional elements and are conditional - the Naval Surface Warfare Center contract is described as potentially worth up to $49.2 million if fully exercised (affects defense and aerospace sectors).
  • The insider sales were executed under a pre-arranged 10b5-1 plan adopted May 20, 2025, which limits interpretation of the transactions as a contemporaneous signal about management sentiment (affects equity market interpretation).
  • Program milestones such as the maiden flight for the integrated Uncrewed Collaborative Combat Aircraft system are planned but not detailed in timing or outcome in the disclosures (affects program delivery timelines in defense/aerospace sectors).

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026